Britannia Pointe Grand Redevelopment

Britannia Pointe Grand is a tenbuilding life sciences campus development consisting of a total 630,528 square feet, located in the heart of South San Francisco’s biotechnology corridor. The project was acquired by HCP, Inc. in 1997 as a partially completed, four building, 177,938 square foot research and development property. HCP, Inc. subsequently assembled various adjacent parcels and completed several additional life sciences facilities over the next several years.

Britannia Pointe Grand is also home to life sciences clients including Cytokinetics, Kalobios, and Millennium Pharmaceuticals. Although the Britannia Pointe Grand project is fully completed, HCP, Inc. initiated entitlement proceedings with the City of South San Francisco to redevelop the initial 177,938 square foot portion of the project. The development consists of three new life sciences buildings (one four story and two five story) and a seven story parking structure totaling approximately 462,000 square feet. Project Management Advisors, Inc. (PMA) was retained by HCP, Inc. to coordinate the entitlement process, including interfacing with the city and select consultants on the Environmental Impact Report and Transportation Demand Management Plan. This process included design review board meetings, and approval by city council.